JPWO2023063296A1 - - Google Patents
Info
- Publication number
- JPWO2023063296A1 JPWO2023063296A1 JP2023554518A JP2023554518A JPWO2023063296A1 JP WO2023063296 A1 JPWO2023063296 A1 JP WO2023063296A1 JP 2023554518 A JP2023554518 A JP 2023554518A JP 2023554518 A JP2023554518 A JP 2023554518A JP WO2023063296 A1 JPWO2023063296 A1 JP WO2023063296A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
- A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021166788 | 2021-10-11 | ||
| PCT/JP2022/037812 WO2023063296A1 (ja) | 2021-10-11 | 2022-10-11 | 混合液の製造方法、混合液、及び、固形組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2023063296A1 true JPWO2023063296A1 (https=) | 2023-04-20 |
Family
ID=85987944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023554518A Pending JPWO2023063296A1 (https=) | 2021-10-11 | 2022-10-11 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240398753A1 (https=) |
| EP (1) | EP4417220A4 (https=) |
| JP (1) | JPWO2023063296A1 (https=) |
| WO (1) | WO2023063296A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120059533B (zh) * | 2025-03-03 | 2025-12-05 | 东方雨虹民用建材有限责任公司 | 抗泛碱聚合物水泥防水涂料及制备方法、复合抗泛碱结构 |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5578965A (en) * | 1978-12-11 | 1980-06-14 | Kokando Kk | Heating smell sendinggforth matter |
| JPH05194196A (ja) * | 1992-01-14 | 1993-08-03 | Eisai Co Ltd | プロナノスフィア及びその製法 |
| JPH11246393A (ja) * | 1998-03-02 | 1999-09-14 | Teijin Ltd | 難溶性薬物の速溶性用時調製用粉剤およびその製造法 |
| JP2008545665A (ja) * | 2005-05-23 | 2008-12-18 | ユニベルシテ ドゥ ジュネーブ | 高体温による処置のための注入可能な超常磁性ナノ粒子および高体温インプラントを形成するための使用 |
| JP2011057856A (ja) * | 2009-09-10 | 2011-03-24 | Jgc Catalysts & Chemicals Ltd | 改質シクロデキストリン粒子分散液及びその製造方法 |
| JP2011231076A (ja) * | 2010-04-30 | 2011-11-17 | Kuroisutaazu :Kk | 顆粒状入浴剤 |
| JP2014177415A (ja) * | 2013-03-13 | 2014-09-25 | Daido Kasei Kogyo Kk | ナノ粒子化製剤及びその製造方法 |
| JP2017509691A (ja) * | 2014-01-21 | 2017-04-06 | ビーピーエスアイ ホールディングス, エルエルシー | 中鎖グリセリドを含有する即時放出フィルムコーティング、及びそれによってコーティングされている基材 |
| WO2019004338A1 (ja) * | 2017-06-28 | 2019-01-03 | 株式会社 先端医療開発 | 医薬組成物及び腫瘍免疫活性促進剤 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4963846B2 (ja) * | 2006-03-03 | 2012-06-27 | エルメッド エーザイ株式会社 | 口腔内崩壊錠及びその製造方法 |
| JP6186032B1 (ja) | 2016-03-31 | 2017-08-23 | ハリマ化成株式会社 | コーティング剤およびコーティング膜 |
| PT3868366T (pt) * | 2018-10-19 | 2024-03-25 | Towa Pharmaceutical Co Ltd | Preparação sólida revestida |
| JP2020093126A (ja) | 2020-03-16 | 2020-06-18 | 株式会社三洋物産 | 遊技機 |
-
2022
- 2022-10-11 JP JP2023554518A patent/JPWO2023063296A1/ja active Pending
- 2022-10-11 EP EP22880991.9A patent/EP4417220A4/en active Pending
- 2022-10-11 WO PCT/JP2022/037812 patent/WO2023063296A1/ja not_active Ceased
- 2022-10-11 US US18/699,647 patent/US20240398753A1/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5578965A (en) * | 1978-12-11 | 1980-06-14 | Kokando Kk | Heating smell sendinggforth matter |
| JPH05194196A (ja) * | 1992-01-14 | 1993-08-03 | Eisai Co Ltd | プロナノスフィア及びその製法 |
| JPH11246393A (ja) * | 1998-03-02 | 1999-09-14 | Teijin Ltd | 難溶性薬物の速溶性用時調製用粉剤およびその製造法 |
| JP2008545665A (ja) * | 2005-05-23 | 2008-12-18 | ユニベルシテ ドゥ ジュネーブ | 高体温による処置のための注入可能な超常磁性ナノ粒子および高体温インプラントを形成するための使用 |
| JP2011057856A (ja) * | 2009-09-10 | 2011-03-24 | Jgc Catalysts & Chemicals Ltd | 改質シクロデキストリン粒子分散液及びその製造方法 |
| JP2011231076A (ja) * | 2010-04-30 | 2011-11-17 | Kuroisutaazu :Kk | 顆粒状入浴剤 |
| JP2014177415A (ja) * | 2013-03-13 | 2014-09-25 | Daido Kasei Kogyo Kk | ナノ粒子化製剤及びその製造方法 |
| JP2017509691A (ja) * | 2014-01-21 | 2017-04-06 | ビーピーエスアイ ホールディングス, エルエルシー | 中鎖グリセリドを含有する即時放出フィルムコーティング、及びそれによってコーティングされている基材 |
| WO2019004338A1 (ja) * | 2017-06-28 | 2019-01-03 | 株式会社 先端医療開発 | 医薬組成物及び腫瘍免疫活性促進剤 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4417220A1 (en) | 2024-08-21 |
| EP4417220A4 (en) | 2025-10-08 |
| WO2023063296A1 (ja) | 2023-04-20 |
| US20240398753A1 (en) | 2024-12-05 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240408 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20240408 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250610 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20250812 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251009 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20251111 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260113 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20260414 |